The UK is urgently recalling a Chinese-made no-rinse disinfectant hand sanitizer because it is not germicidal enough to prevent disease and contains highly toxic methanol.
According to the Chartered Trading Standards Institute, the ethanol concentration in the Chinese-made hand sanitizer is only 7 percent, which is not enough to kill bacteria, but it contains 37 percent methanol. Both the U.K. and the U.S. have banned methanol in hand sanitizers.
The Daily Mirror reports that ingesting or being exposed to methanol carries a risk of poisoning, with possible side effects including headaches, blurred vision, nausea, vomiting, dyscalculia and even death. The Daily Mail UK reports that methanol can trigger toxic reactions, blindness and death after it is metabolized by the body.
The product name of this hand sanitizer is “lbcccndc Instant Hand Sanitiser” and the manufacturer is “Guangzhou Sizhu Network Technology Co”.
The hand sanitizer has been removed from overseas online shopping platforms. However, Alibaba, a mainland platform, has not yet removed the product and marked it as “export certified”.
In addition to hand sanitizer, a variety of other products exported by the Chinese Communist Party to overseas have been exposed as being of poor quality, especially the epidemic prevention products that the Communist Party has been exporting to overseas since the outbreak of the epidemic. Many countries around the world have continued to find quality problems with the Communist Party’s exported epidemic prevention products, including masks, protective clothing, and testing reagents.
Foreign media recently obtained an internal document from the CCP’s Hengshui Foreign Affairs Office in Hebei province, showing that the U.S. government has launched a forensic investigation of Chinese companies exporting shoddy epidemic prevention products.
Recently, the CCP has been vigorously marketing the new coronavirus vaccine overseas, for example, exporting it to overseas for a few tens of yuan, while asking hundreds of yuan for it within the mainland.
However, the efficiency of the CCP’s vaccine has been questioned. The Instituto Butantan in São Paulo, Brazil, announced about a week or so ago that the mainland’s Coxin vaccine was 78 percent effective, but announced on Jan. 12 that its effectiveness had been revised downward to 50.38 percent.
The Peruvian health unit said on Dec. 12, 2020, that a volunteer had developed “neurological symptoms” and had difficulty moving his arms after receiving the vaccine developed by China National Pharmaceutical Group, and that the clinical trial of the vaccine had been urgently suspended.
Recent Comments